Items Tagged ‘Regeneron’

November 21, 2019

Rochester cancer therapy firm to collaborate with drugmaker on melanoma treatment

By Karl Oestreich Karl Oestreich

Star Tribuneby Joe Carlson Vyriad, a company in southeastern Minnesota that is designing viruses to selectively kill cancer cells, has signed a major agreement with the biotech drugmaker Regeneron to collaborate on a drug therapies to target melanoma and cancers of the lung, liver and uterus. A Vyriad spokesman said the agreement would lead to […]

View full entry

Tags: Cancer, Dr. Stephen Russell, Imanis Life Sciences, oncolytic virotherapy, Regeneron, Star Tribune, Vyriad


November 8, 2019

Mayo Clinic in the News Weekly Highlights for November 8, 2019

By Emily Blahnik Emily Blahnik

Quartz, Rare genetic mutations protected a woman from developing Alzheimer’s by Katherine Ellen Foley — This case study “leads us to think about the importance of such studies in relatively understudied populations,” says Nilufer Ertekin-Taner, a neurogeneticist with the Mayo Clinic in Jacksonville, Florida, who was not involved with the study. Scientific knowledge of the […]

View full entry

Tags: Andrea Malenya, Anne Bauch, anxiety, artificial Intelligence, bariatric surgery, biotech, Breast Cancer, Bu, Cancer, cardiovascular disease, Chemotherapy, Children's Center


August 16, 2019

Mayo Clinic in the News Weekly Highlights for August 16, 2019

By Emily Blahnik Emily Blahnik

Wall Street Journal, Deals Give Drugmakers Rights to DNA Data by Melanie Evans — Deals between drugmakers and hospital systems to mine the genetic profiles of hospital patients are triggering concerns over the control of valuable genetic data. Drugmakers have been spending hundreds of millions of dollars for access to patient information because of the […]

View full entry

Tags: Amy Stelpflug, anxiety, artificial Intelligence, backpacks, belly fat, Breast Cancer, cardio, carpal tunnel syndrome, celiac disease, chronic pain, climate change, cross training



Contact Us · Privacy Policy